Cargando…

Disease burden and vaccination priorities in Colombia

INTRODUCTION: In the context of the COVID-19 pandemic, vaccination is considered a potentially effective strategy for controlling the disease. The objective of this study is to estimate the number of people with a high risk of morbidity and those who should be prioritized in immunization planning in...

Descripción completa

Detalles Bibliográficos
Autores principales: Quitián, Lina María, Rodríguez-Martinez, Carlos E., Sossa-Briceño, Mónica P., Cortés, Jorge Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844975/
https://www.ncbi.nlm.nih.gov/pubmed/35181150
http://dx.doi.org/10.1016/j.vaccine.2022.01.014
_version_ 1784651580661825536
author Quitián, Lina María
Rodríguez-Martinez, Carlos E.
Sossa-Briceño, Mónica P.
Cortés, Jorge Alberto
author_facet Quitián, Lina María
Rodríguez-Martinez, Carlos E.
Sossa-Briceño, Mónica P.
Cortés, Jorge Alberto
author_sort Quitián, Lina María
collection PubMed
description INTRODUCTION: In the context of the COVID-19 pandemic, vaccination is considered a potentially effective strategy for controlling the disease. The objective of this study is to estimate the number of people with a high risk of morbidity and those who should be prioritized in immunization planning in Colombia. MATERIALS AND METHODS: The population at risk by age was identified from the national census data of 2018. Various sources were identified to obtain information on the number of patients with different comorbidities, including heart failure, diabetes, chronic kidney failure, cancers, HIV infection, and obesity. Sources were also identified to estimate the number of health workers, teachers and military and police force personnel. RESULTS: By 2021, Colombia is estimated to have a total of 51,049,498 inhabitants, of whom 14% will be people over 60 years of age. Additionally, of the people with comorbidities younger than 60 years old, 5,233,241 inhabitants are expected to be obese, 592,726 are expected to have diabetes mellitus, 216,389 are expected to have chronic kidney disease, and 521,263 are expected to have heart failure, totaling 15,055,697 individuals. Combining the high-priority groups and health workers, a projected 20 million people will have mortality risk factors. CONCLUSIONS: For Colombia’s vaccination strategy to have an impact on reducing mortality, population groups with risk factors, corresponding to approximately 15 million inhabitants, as well as essential workers should be prioritized.
format Online
Article
Text
id pubmed-8844975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88449752022-02-15 Disease burden and vaccination priorities in Colombia Quitián, Lina María Rodríguez-Martinez, Carlos E. Sossa-Briceño, Mónica P. Cortés, Jorge Alberto Vaccine Short Communication INTRODUCTION: In the context of the COVID-19 pandemic, vaccination is considered a potentially effective strategy for controlling the disease. The objective of this study is to estimate the number of people with a high risk of morbidity and those who should be prioritized in immunization planning in Colombia. MATERIALS AND METHODS: The population at risk by age was identified from the national census data of 2018. Various sources were identified to obtain information on the number of patients with different comorbidities, including heart failure, diabetes, chronic kidney failure, cancers, HIV infection, and obesity. Sources were also identified to estimate the number of health workers, teachers and military and police force personnel. RESULTS: By 2021, Colombia is estimated to have a total of 51,049,498 inhabitants, of whom 14% will be people over 60 years of age. Additionally, of the people with comorbidities younger than 60 years old, 5,233,241 inhabitants are expected to be obese, 592,726 are expected to have diabetes mellitus, 216,389 are expected to have chronic kidney disease, and 521,263 are expected to have heart failure, totaling 15,055,697 individuals. Combining the high-priority groups and health workers, a projected 20 million people will have mortality risk factors. CONCLUSIONS: For Colombia’s vaccination strategy to have an impact on reducing mortality, population groups with risk factors, corresponding to approximately 15 million inhabitants, as well as essential workers should be prioritized. Elsevier Ltd. 2022-03-15 2022-02-15 /pmc/articles/PMC8844975/ /pubmed/35181150 http://dx.doi.org/10.1016/j.vaccine.2022.01.014 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Quitián, Lina María
Rodríguez-Martinez, Carlos E.
Sossa-Briceño, Mónica P.
Cortés, Jorge Alberto
Disease burden and vaccination priorities in Colombia
title Disease burden and vaccination priorities in Colombia
title_full Disease burden and vaccination priorities in Colombia
title_fullStr Disease burden and vaccination priorities in Colombia
title_full_unstemmed Disease burden and vaccination priorities in Colombia
title_short Disease burden and vaccination priorities in Colombia
title_sort disease burden and vaccination priorities in colombia
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844975/
https://www.ncbi.nlm.nih.gov/pubmed/35181150
http://dx.doi.org/10.1016/j.vaccine.2022.01.014
work_keys_str_mv AT quitianlinamaria diseaseburdenandvaccinationprioritiesincolombia
AT rodriguezmartinezcarlose diseaseburdenandvaccinationprioritiesincolombia
AT sossabricenomonicap diseaseburdenandvaccinationprioritiesincolombia
AT cortesjorgealberto diseaseburdenandvaccinationprioritiesincolombia